Skip to main content
SpringerLink
Log in
Book cover

Handbook of Neurochemistry and Molecular Neurobiology pp 499–522Cite as

Hypocretins/Orexins in Brain Function

  • Reference work entry
  • First Online:

  • 778 Accesses

Abstract:

The hypocretins (also called the orexins) are two C-terminally amidated neuropeptides of related sequence. They are produced from a common precursor whose expression is restricted to a few thousand neurons of the rat dorsolateral hypothalamus. Two G‐protein‐coupled receptors (GPCRs) for the hypocretins have been identified, and these have different distributions within the CNS and differential affinities for the two hypocretins. The hypocretins have been detected in secretory vesicles at synapses of fibers that project to areas within the posterior hypothalamus that are implicated in feeding behaviors and hormone secretion. Hypocretin fibers also project to diverse targets in other brain regions and the spinal cord, including several areas implicated in cardiovascular function and sleep–wake regulation. The peptides are excitatory when applied directly in vivo and to cultured neurons and slices, although there is also evidence for some inhibitory signaling. Administration of the hypocretins stimulates food intake, affects blood pressure, hormone secretion, and locomotor activity, and increases wakefulness while suppressing rapid eye movement (REM) sleep. Inactivating mutations in the hypocretin receptor 2 gene (hcrtr 2) in dogs result in narcolepsy. Mice whose hypocretin gene has been inactivated exhibit a narcolepsy‐like phenotype. Most human patients with narcolepsy have greatly reduced levels of hypocretin peptides in their cerebrospinal fluid (CSF) and no or barely detectable hypocretin neurons in their hypothalami, suggestive of autoimmune attack. One aspect of hypocretin activity is the direct excitation of cholinergic forebrain neurons, brainstem monoaminergic REM‐off neurons in the locus coeruleus and dorsal raphe nucleus, and histaminergic tuberomammillary nucleus (TMN), which together suppress slow‐wave sleep. The hypocretins also modulate the activity of cholinergic REM‐on neurons in the brainstem, which gate REM entry. The effects on wakefulness appear to be the dominant activities of the hypocretin system and are twofold: maintenance of the waking state and suppression of REM entry.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   249.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Abbreviations

AgRP:

agouti‐related peptide

CRF:

corticotropin‐releasing factor

CSF:

cerebrospinal fluid

DMH:

dorsomedial hypothalamus

EEG:

electroencephalogram

GPCR:

G‐protein‐coupled receptor

Hcrt:

hypocretin

Hcrtr1, 2:

hypocretin receptors 1, 2

ICV:

intracerebroventricular administration

LC:

locus coeruleus

LDT:

laterodorsal tegmentum

LH:

lateral hypothalamus

LHSS:

lateral hypothalamus self‐stimulation

MCH:

melanin‐concentrating hormone

PKC:

protein kinase C

PPT:

pedunculopontine nucleus

PVN:

paraventricular nucleus

REM:

rapid eye movement sleep

SCN:

suprachiasmatic nucleus

TMN:

tuberomammillary nucleus

VTA:

ventral tegmental area

References

  • Abrahamson EE, Leak RK, Moore RY. 2001. The suprachiasmatic nucleus projects to posterior hypothalamic arousal systems. Neuroreport 12: 435–440.

    CAS  PubMed  Google Scholar 

  • Alam MN, Gong H, Alam T, Jaganath R, McGinty D, et al 2002. Sleep‐waking discharge patterns of neurons recorded in the rat perifornical lateral hypothalamic area. J Physiol 538: 619–631.

    CAS  PubMed  Google Scholar 

  • Al Barazanji KA, Wilson S, Baker J, Jessop DS, Harbuz MS. 2001. Central orexin‐A activates hypothalamic–pituitary–adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats. J Neuroendocrinol 13: 421–424.

    CAS  PubMed  Google Scholar 

  • Alvarez CE, Sutcliffe JG. 2002. Hypocretin is an early member of the incretin gene family. Neurosci Lett 324: 169–172.

    CAS  PubMed  Google Scholar 

  • Anand BK, Brobeck JR. 1951a. Hypothalamic control of food intake in rats and cats. Yale J Biol Med 24: 123–140.

    CAS  Google Scholar 

  • Anand BK, Brobeck JR. 1951b. Localization of a “feeding center” in the hypothalamus of the rat. Proc Soc Exp Biol Med 77: 323–324.

    CAS  Google Scholar 

  • Asahi S, Egashira S, Matsuda M, Iwaasa H, Kanatani A, et al. 2000. Structure–activity relationship studies on the novel neuropeptide orexin. Peptide science. Fujii N, editor. The Japanese Peptide Society, Tokyo, pp. 37-40.

    Google Scholar 

  • Aston‐Jones G, Bloom FF. 1981. Activity of norepinephrine‐containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep‐waking cycle. J Neurosci 1: 876–886.

    PubMed  Google Scholar 

  • Bayer L, Colard C, Nguyen NU, Risold PY, Fellmann D, et al 2000. Alteration of the expression of the hypocretin (orexin) gene by 2‐deoxyglucose in the rat lateral hypothalamic area. Neuroreport 11: 531–533.

    CAS  PubMed  Google Scholar 

  • Bayer L, Eggermann E, Saint‐Mleux B, Machard D, Jones BE, et al 2002a. Selective action of orexin (hypocretin) on nonspecific thalamocortical projection neurons. J Neurosci 22: 7835–7839.

    CAS  Google Scholar 

  • Bayer L, Eggermann E, Serafin M, Saint‐Mleux B, Machard D, et al 2001. Orexins (hypocretins) directly excite tuberomammillary neurons. Eur J Neurosci 14: 1571–1575.

    CAS  PubMed  Google Scholar 

  • Bayer L, Mairet‐Coello G, Risold PY, Griffond B. 2002b. Orexin/hypocretin neurons: chemical phenotype and possible interactions with melanin‐concentrating hormone neurons. Regul Pept 104: 33–39.

    CAS  Google Scholar 

  • Bayer L, Saint‐Mleux B, Serafin M, Eggermann E, Machard D, et al 2004. Exclusive postsynaptic action of hypocretin‐orexin on sublayer 6b cortical neurons. J Neurosci 24: 6760–6764.

    CAS  PubMed  Google Scholar 

  • Beck B, Richy S. 1999. Hypothalamic hypocretin/orexin and neuropeptide Y: divergent interaction with energy depletion and leptin. Biochem Biophys Res Commun 258: 119–122.

    CAS  PubMed  Google Scholar 

  • Bingham S, Davey PT, Babbs AJ, Irving EA, Sammons MJ, et al 2001. Orexin‐A, an hypothalamic peptide with analgesic properties. Pain 92: 81–90.

    CAS  PubMed  Google Scholar 

  • Bourgin P, Huitron S, Spier AD, Morte B, Criado JR, et al 2000. Hypocretin‐1 modulates REM sleep through activation of locus coeruleus neurons. J Neurosci 20: 7760–7765.

    CAS  PubMed  Google Scholar 

  • Broberger C, de Lecea L, Sutcliffe JG, Hökfelt T. 1998. Hypocretin/orexin‐ and melanin‐concentrating hormone‐expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and Agouti gene‐related protein systems. J Comp Neurol 402: 460–474.

    CAS  PubMed  Google Scholar 

  • Brown RE, Sergeeva OA, Eriksson KS Haas HL. 2002. Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline). J Neurosci 22: 8850–8859.

    CAS  PubMed  Google Scholar 

  • Burlet S, Tyler CJ, Leonard CS. 2002. Direct and indirect excitation of laterodorsal tegmental neurons by hypocretin/orexin peptides: implications for wakefulness and narcolepsy. J Neurosci 22: 2862–2872.

    CAS  PubMed  Google Scholar 

  • Cai XJ, Evans ML, Lister CA, Leslie RA, Arch JR, et al 2001. Hypoglycemia activates orexin neurons and selectively increases hypothalamic orexin‐B levels: responses inhibited by feeding and possibly mediated by the nucleus of the solitary tract. Diabetes 50: 105–112.

    CAS  PubMed  Google Scholar 

  • Campbell RE, Smith MS, Allen SE, Grayson BE, Ffrench‐Mullen JM, et al 2003. Orexin neurons express a functional pancreatic polypeptide Y4 receptor. J Neurosci 23: 1487–1497.

    CAS  PubMed  Google Scholar 

  • Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, et al 1999. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98: 437–451.

    CAS  PubMed  Google Scholar 

  • Chen CT, Hwang LL, Chang JK, Dun NJ. 2000. Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats. Am J Physiol Regul Integr Comp Physiol 278: R692–R697.

    CAS  PubMed  Google Scholar 

  • Chou TC, Lee CE, Lu J, Elmquist JK, Hara J, et al 2001. Orexin (hypocretin) neurons contain dynorphin. J Neurosci 21: RC168 (1–6).

    Google Scholar 

  • Chou TC, Scammell TE, Gooley JJ, Gaus SE, Saper CB, et al 2003. Critical role of dorsomedial hypothalamic nucleus in a wide range of behavioral circadian rhythms. J Neurosci 23: 10691–10702.

    CAS  PubMed  Google Scholar 

  • Clancy B, Cauller L. 1999. Widespread projections from subgriseal neurons (layer VII) to layer I in adult rat cortex. J Comp Neurol 407: 275–286.

    CAS  PubMed  Google Scholar 

  • Collin M, Backberg M, Ovesjo ML, Fisone G, Edwards RH, et al 2003. Plasma membrane and vesicular glutamate transporter mRNAs/proteins in hypothalamic neurons that regulate body weight. Eur J Neurosci 18: 1265–1278.

    PubMed  Google Scholar 

  • Corrigall W. 1987. Heroin self‐administration: effects of antagonist treatment in lateral hypothalamus. Pharmacol Biochem Behav 27: 693–700.

    CAS  PubMed  Google Scholar 

  • Dampney RAL. 1994. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 74: 323–364.

    CAS  PubMed  Google Scholar 

  • Date Y, Ueta Y, Yamashita H, Yamaguchi H, Matsujura S, et al 1999. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci USA 96: 748–753.

    CAS  PubMed  Google Scholar 

  • de Lecea L, Criado JR, Prospero‐Garcia O, Gautvik KM, Schweitzer P, et al 1996. A cortical neuropeptide with neuronal depressant and sleep‐modulating properties. Nature 381: 242–245.

    CAS  PubMed  Google Scholar 

  • de Lecea L, Kilduff TS, Peyron C, Gao X‐B, Foye PE, et al 1998. The hypocretins: hypothalamus‐specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95: 322–327.

    CAS  PubMed  Google Scholar 

  • Dube MG, Kalra SP, Kalra P. 1999. Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action. Brain Res 842: 473–477.

    CAS  PubMed  Google Scholar 

  • Duxon MS, Stretton J, Starr K, Jones DNC, Holland V, et al 2001. Evidence that orexin‐A‐evoked grooming in the rat is mediated by orexin‐1 (OX1) receptors, with downstream 5‐HT2C receptor involvement. Psychopharmacology (Berl)153: 203–209.

    CAS  Google Scholar 

  • Edwards CM, Abusnana S, Sunter D, Murphy KG, Ghatei MA, et al 1999. The effect of the orexins on food intake: comparison with neuropeptide Y, melanin‐concentrating hormone and galanin. J Endocrinol 160: R7–R12.

    CAS  PubMed  Google Scholar 

  • Eggermann E, Serafin M, Bayer L, Machard D, Saint‐Mleux B, et al 2001. Orexins/hypocretins excite basal forebrain cholinergic neurons. Neuroscience 108: 177–181.

    CAS  PubMed  Google Scholar 

  • Elias CF, Saper CB, Maratos‐Flier E, Tritos NA, Lee C, et al 1998. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J Comp Neurol 402: 442–459.

    CAS  PubMed  Google Scholar 

  • Ennis M, Aston‐Jones G. 1989. GABA‐mediated inhibition of locus coeruleus from the dorsomedial rostral medulla. J Neurosci 9: 2973–2981.

    CAS  PubMed  Google Scholar 

  • Eriksson KS, Sergeeva O, Brown RE, Haas HL. 2001. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J Neurosci 21: 9273–9279.

    CAS  PubMed  Google Scholar 

  • Espana RA, Baldo BA, Kelley AE, Berridge CW. 2001. Wake‐promoting and sleep‐suppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience 106: 699–715.

    CAS  PubMed  Google Scholar 

  • Estabrooke IV, McCarthy MT, Ko E, Chou TC, Chemelli RM, et al 2001. Fos expression in orexin neurons varies with behavioral state. J Neurosci 21: 1656–1662.

    CAS  PubMed  Google Scholar 

  • Fadel J, Deutch AY. 2002. Anatomical substrates of orexin‐dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 111: 379–387.

    CAS  PubMed  Google Scholar 

  • Follwell MJ, Ferguson AV. 2002. Cellular mechanisms of orexin actions on paraventricular nucleus neurones in rat hypothalamus. J Physiol 545: 855–867.

    CAS  PubMed  Google Scholar 

  • Forster GL, Blaha CD. 2000. Laterodorsal tegmental stimulation elicits dopamine efflux in the rat nucleus accumbens by activation of acetylcholine and glutamate receptors in the ventral tegmental area. Eur J Neurosci 12: 3596–3604.

    CAS  PubMed  Google Scholar 

  • Fujiki N, Yoshida Y, Ripley B, Honda K, Mignot E, et al 2001. Changes in CSF hypocretin‐1 (orexin A) levels in rats across 24 hours and in response to food deprivation. Neuroreport 12: 993–997.

    CAS  PubMed  Google Scholar 

  • Gautvik KM, de Lecea L, Gautvik VT, Danielson PE, Tranque P, et al 1996. Overview of the most prevalent hypothalamus‐specific mRNAs, as identified by directional tag PCR subtraction. Proc Natl Acad Sci USA 93: 8733–8738.

    CAS  PubMed  Google Scholar 

  • Georgescu D, Zachariou V, Barrot M, Mieda M, Willie JT, et al 2003. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci 23: 3106–3111.

    CAS  PubMed  Google Scholar 

  • Gerashchenko D, Kohls MD, Greco M, Waleh NS, Salin‐Pascual R, et al 2001. Hypocretin‐2‐saporin lesions of the lateral hypothalamus produce narcoleptic‐like sleep behavior in the rat. J Neurosci 21 : 7273–7283.

    CAS  PubMed  Google Scholar 

  • Griffond B, Risold PY, Jacquemard C, Colard C, Fellmann D. 1999. Insulin‐induced hypoglycemia increases preprohypocretin (orexin) mRNA in the rat lateral hypothalamic area. Neurosci Lett 262: 77–80.

    CAS  PubMed  Google Scholar 

  • Gronenborn AM, Bovermann G, Clore GM. 1987. A 1H‐NMR study of the solution conformation of secretin. Resonance assignment and secondary structure. FEBS Lett 215: 88–94.

    CAS  Google Scholar 

  • Grudt TJ, van den Pol AN, Perl ER. 2002. Hypocretin‐2 (orexin‐B) modulation of superficial dorsal horn activity in rat. J Physiol 538: 517–525.

    CAS  PubMed  Google Scholar 

  • Guan JL, Uehara K, Lu S, Wang QP, Funahashi H, et al 2002. Reciprocal synaptic relationships between orexin‐ and melanin‐concentrating hormone‐containing neurons in the rat lateral hypothalamus: a novel circuit implicated in feeding regulation. Int J Obes Relat Metab Disord 26: 1523–1532.

    CAS  PubMed  Google Scholar 

  • Hagan JJ, Leslie RA, Patel S, Evans ML, Wattam TA, et al 1999. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA 96: 10911–10916.

    CAS  PubMed  Google Scholar 

  • Hakansson M, de Lecea L, Sutcliffe JG, Yanagisawa M, Meister B. 1999. Leptin receptor‐and STAT3‐immunoreactivities in hypocretin/orexin neurons of the lateral hypothalamus. J Neuroendocrinol 11: 653–663.

    CAS  PubMed  Google Scholar 

  • Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, et al 2001. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30: 345–354.

    CAS  PubMed  Google Scholar 

  • Haynes AC, Chapman H, Taylor C, Moore GBT, Cawthorne MA, et al 2002. Anorectic, thermogenic and anti‐obesity activity of a selective orexin‐1 receptor antagonist in ob/ob mice. Regul Pept 104: 153–159.

    CAS  PubMed  Google Scholar 

  • Hervieu GJ, Cluderay JE, Harrison DC, Roberts JC, Leslie RA. 2001. Gene expression and protein distribution of the orexin‐1 receptor in the rat brain and spinal cord. Neuroscience 103: 777–797.

    CAS  PubMed  Google Scholar 

  • Hetherington AW, Ranson SW. 1940. Hypothalamic lesions and adiposity in the rat. Anat Rec 78: 149–172.

    Google Scholar 

  • Higuchi S, Usui A, Murasaki M, Matsushita S, Nishioka N, et al 2002. Plasma orexin‐A lower is lower in patients with narcolepsy. Neurosci Lett 318: 61–64.

    CAS  PubMed  Google Scholar 

  • Hirose M, Egashira S, Goto Y, Hashihayata T, Ohtake N, et al 2003. N‐acyl 6,7‐dimethoxy‐1,2,3,4‐tetrahydroisoquinoline: the first orexin‐2 receptor selective non‐peptidic antagonist. Bioorg Med Chem Lett 13: 4497–4499.

    CAS  PubMed  Google Scholar 

  • Hobson JA, McCarley RW, Wyzinski PW. 1975. Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science 189: 55–58.

    CAS  PubMed  Google Scholar 

  • Hobson JA, Pace‐Schott EF. 2002. The cognitive neuroscience of sleep: neuronal systems, consciousness and learning. Nat Rev Neurosci 3: 679–693.

    CAS  PubMed  Google Scholar 

  • Horvath TL, Diano S, van den Pol A. 1999a. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. J Neurosci 19: 1072–1087.

    CAS  Google Scholar 

  • Horvath TL, Peyron C, Diano S, Ivanov A, Aston‐Jones, G, et al 1999b. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J Comp Neurol 415: 145–159.

    CAS  Google Scholar 

  • Huang ZL, Qu WM, Li WD, Mochizuki T, Eguchi N, et al 2001. Arousal effect of orexin A depends on activation of the histaminergic system. Proc Natl Acad Sci USA 98: 9965–9970.

    CAS  PubMed  Google Scholar 

  • Hungs M, Fan J, Lin L, Lin X, Maki RA, et al 2001. Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines. Genome Res 11: 531–539.

    CAS  PubMed  Google Scholar 

  • Hungs M, Mignot E. 2001. Hypocretin/orexin, sleep and narcolepsy. Bioessays 23: 397–408.

    CAS  PubMed  Google Scholar 

  • Hwang LL, Chen CT, Dun NJ. 2001. Mechanisms of orexin‐induced depolarizations in rat dorsal motor nucleus of vagus neurones in vitro. J Physiol 537: 511–520.

    CAS  PubMed  Google Scholar 

  • Ida T, Nakahara K, Katayama T, Murakami N, Nakazato M. 1999. Effect of lateral cerebroventricular injection of the appetite‐stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats. Brain Res 821: 526–529.

    CAS  PubMed  Google Scholar 

  • Ida T, Nakahara K, Murakami T, Hanada R, Nakazato M, et al 2000. Possible involvement of orexin in the stress reaction in rats. Biochem Biophys Res Commun 270: 318–323.

    CAS  PubMed  Google Scholar 

  • Iqbal J, Pompolo S, Sakurai T, Clarke IJ. 2001. Evidence that orexin‐containing neurones provide direct input to gonadotropin‐releasing hormone neurones in the ovine hypothalamus. J Neuroendocrinol 13: 1033–1041.

    CAS  PubMed  Google Scholar 

  • Ishii Y, Blundell JE, Halford JCG, Upton N, Porter R, et al 2004. Differential effects of the selective orexin‐1 receptor antagonist SB‐334867 and lithium chloride on the behavioural satiety sequence in rats. Physiol Behav 81: 129–140.

    CAS  PubMed  Google Scholar 

  • Ivanov A, Aston‐Jones G. 2000. Hypocretin/orexin depolarizes and decreases potassium conductance in locus coeruleus neurons. Neuroreport 11: 1755–1758.

    CAS  PubMed  Google Scholar 

  • Jain MR, Horvath TL, Kalra PS, Kalra SP. 2000. Evidence that NPY Y1 receptors are involved in stimulation of feeding by orexins (hypocretins) in sated rats. Regul Pept 87: 19–24.

    CAS  PubMed  Google Scholar 

  • John J, Wu MF, Boehmer LN, Siegel JM. 2004. Cataplexy‐active neurons in the hypothalamus: implications for the role of histamine in sleep and waking behavior. Neuron 42: 619–634.

    CAS  PubMed  Google Scholar 

  • Jones B. 1994. Basic mechanisms of sleep‐wake states. Principles and practice of sleep medicine. Kryger M, Roth T, Dement WC, editors. Philadelphia, Pennsylvania: WB Saunders, pp. 145–162.

    Google Scholar 

  • Jones DN, Gartlon J, Parker F, Taylor SG, Routledge C, et al 2001. Effects of centrally administered orexin‐B and orexin‐A: a role for orexin‐1 receptors in orexin‐B‐induced hyperactivity. Psychopharmacology 153: 210–218.

    CAS  PubMed  Google Scholar 

  • Karteris E, Randeva HS, Grammatopoulos DK, Jaffe RB, Hillhouse EW. 2001. Expression and coupling characteristics of the CRH and orexin type 2 receptors in human fetal adrenals. J Clin Endocrinol Metab 86: 4512–4519.

    CAS  PubMed  Google Scholar 

  • Kilduff TS, de Lecea L. 2001. Mapping of the mRNAs for the hypocretin/orexin and melanin‐concentrating hormone receptors: networks of overlapping peptide systems. J Comp Neurol 435: 1–5.

    CAS  PubMed  Google Scholar 

  • Kirchgessner AL, Liu M. 1999. Orexin synthesis and response in the gut. Neuron 24: 941–951.

    CAS  PubMed  Google Scholar 

  • Korotkova TM, Eriksson KS, Haas HL, Brown RE. 2002. Selective excitation of GABAergic neurons in the substantia nigra of the rat by orexin/hypocretin in vitro. Regul Pept 104: 83–89.

    CAS  PubMed  Google Scholar 

  • Kukkonen JP, Akerman KE. 2001. Orexin receptors couple to Ca2+ channels different from store‐operated Ca2+ channels. Neuroreport 12: 2017–2020.

    CAS  PubMed  Google Scholar 

  • Kunii K, Yamanaka A, Nambu T, Matsuzaki I, Goto K, et al 1999. Orexins/ hypocretins regulate drinking behaviour. Brain Res 842: 256–261.

    CAS  PubMed  Google Scholar 

  • Kuru M, Ueta Y, Serino R, Nakazato M, Yamamoto Y, et al 2000. Centrally administered orexin/hypocretin activates HPA axis in rats. Neuroreport 11: 1977–1980.

    CAS  PubMed  Google Scholar 

  • Kushikata T, Hirota K, Yoshida H, Kudo M, Lambert DG, et al 2003. Orexinergic neurons and barbiturate anesthesia. Neuroscience 121: 855–863.

    CAS  PubMed  Google Scholar 

  • Lang M, Söll R, Dürrenberger F, Dautzenberg FM, Beck‐Sickinger AG. 2004. Structure‐activity studies of orexin A and orexin B at the human orexin 1 and orexin 2 receptors led to orexin 2 receptor selective and orexin 1 receptor preferring ligands. J Med Chem 47: 1153–1160.

    CAS  PubMed  Google Scholar 

  • Lee JH, Bang E, Chae KJ, Kim JY, Lee DW, et al 1999. Solution structure of a new hypothalamic neuropeptide, human hypocretin‐2/orexin‐B. Eur J Biochem 299: 831–839.

    Google Scholar 

  • Li Y, Gao XB, Sakurai T, van den Pol AN. 2002. Hypocretin/orexin excites hypocretin neurons via a local glutamate neuron‐A potential mechanism for orchestrating the hypothalamic arousal system. Neuron 36: 1169–1181.

    CAS  PubMed  Google Scholar 

  • Lin L, Faraco J, Li R, Kadotani H, Rogers W, et al 1999. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98: 365–376.

    CAS  PubMed  Google Scholar 

  • Lin L, Hungs M, Mignot E. 2001. Narcolepsy and the HLA region. J Neuroimmunol 117: 9–20.

    CAS  PubMed  Google Scholar 

  • Liu RJ, van den Pol AN, Aghajanian GK. 2002. Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J Neurosci 22: 9453–9464.

    CAS  PubMed  Google Scholar 

  • Lopez M, Seoane L, Garcia MC, Lago F, Casanueva FF, et al 2000. Leptin regulation of prepro‐orexin and orexin receptor mRNA levels in the hypothalamus. Biochem Biophys Res Commun 269: 41–45.

    CAS  PubMed  Google Scholar 

  • Malendowicz LK, Tortorella C, Nussdorfer GG. 1999. Orexins stimulate corticosterone secretion of rat adrenocortical cells, through the activation of the adenylate cyclase‐dependent signaling cascade. J Steroid Biochem Mol Biol 70: 185–188.

    CAS  PubMed  Google Scholar 

  • Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, et al 2001. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 435: 6–25.

    CAS  PubMed  Google Scholar 

  • Martin G, Fabre V, Siggins GR, de Lecea L. 2002. Interaction of the hypocretins with neurotransmitters in the nucleus accumbens. Regul Pept 104: 111–117.

    CAS  PubMed  Google Scholar 

  • McCormick DA, Bal T. 1997. Sleep and arousal: thalamocortical mechanisms. Annu Rev Neurosci 20: 185–215.

    CAS  PubMed  Google Scholar 

  • Mignot E, Lammers G, Ripley B, Okun M, Nevsimalova S, et al 2002. The role of CSF hypocretin measurements in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 59: 1553–1562.

    PubMed  Google Scholar 

  • Mignot E, Lin L, Rogers W, Honda Y, Qiu X, et al 2001. Complex HLA‐DR and ‐DQ interactions confer risk of narcolepsy–cataplexy in three ethnic groups. Am J Hum Genet 68: 686–699.

    CAS  PubMed  Google Scholar 

  • Mikkelsen JD, Hauser F, de Lecea L, Sutcliffe JG, Kilduff TS, et al 2001. Hypocretin (orexin) in the rat pineal gland: a central transmitter with effects on noradrenaline‐induced release of melatonin. Eur J Neurosci 14: 419–425.

    CAS  PubMed  Google Scholar 

  • Mondal MS, Nakazato M, Date Y, Murakami N, Yanagisawa M, et al 1999. Widespread distribution of orexin in rat brain and its regulation upon fasting. Biochem Biophys Res Commun 256: 495–499.

    CAS  PubMed  Google Scholar 

  • Moore RY, Abrahamson EA, van den Pol A. 2001. The hypocretin neuron system: an arousal system in the human brain. Arch Ital Biol 139: 195–205.

    CAS  PubMed  Google Scholar 

  • Moragues N, Ciofi P, Lafon P, Tramu G, Garret M. 2003. GABAA receptor epsilon subunit expression in identified peptidergic neurons of the rat hypothalamus. Brain Res 967: 285–289.

    CAS  PubMed  Google Scholar 

  • Moriguchi T, Sakurai T, Nambu T, Yanagisawa M, Goto K. 1999. Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin‐induced acute hypoglycemia. Neurosci Lett 264: 101–104.

    CAS  PubMed  Google Scholar 

  • Muraki Y, Yamanaka A, Tsujino N, Kilduff TS, Goto K, et al 2004. Serotonergic regulation of the orexin/hypocretin neurons through the 5‐HT1A receptor. J Neurosci 24: 7159–7166.

    CAS  PubMed  Google Scholar 

  • Muroya S, Uramura K, Sakurai T, Takigawa M, Yada T. 2001. Lowering glucose concentrations increases cytosolic Ca2+ in orexin neurons of the rat lateral hypothalamus. Neurosci Lett 309: 165–168.

    CAS  PubMed  Google Scholar 

  • Niimi M, Sato M, Taminato TJ. 2001. Neuropeptide Y in central control of feeding and interactions with orexin and leptin. Endocrine 14: 269–273.

    CAS  PubMed  Google Scholar 

  • Nilaweera KN, Barrett P, Mercer JG, Morgan PJ. 2003. Precursor‐protein convertase 1 gene expression in the mouse hypothalamus: differential regulation by ob gene mutation, energy deficit and administration of leptin, and coexpression with prepro‐orexin. Neuroscience 119: 713–720.

    CAS  PubMed  Google Scholar 

  • Nishino S, Fujiki N, Yoshida Y, Mignot E. 2003. The effects of hypocretin‐1 in hypocretin receptor‐2 mutated and hypocretin deficient narcoleptic dogs. Sleep 26: A287.

    Google Scholar 

  • Nishino S, Ripley B, Overeem S, Lammers JG, Mignot E. 2000. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355: 39–40.

    CAS  PubMed  Google Scholar 

  • Nishino S, Ripley B, Overeem S, Nevsimalova S, Lammers GJ, et al 2001. Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol 50: 381–388.

    CAS  PubMed  Google Scholar 

  • Nowak KW, Mackowiak P, Switonska MM, Fabis M, Malendowicz LK. 2000. Acute orexin effects on insulin secretion in the rat: in vivo and in vitro studies. Life Sci 66: 449–454.

    CAS  PubMed  Google Scholar 

  • Olds J. 1962. Hypothalamic substrates of reward. Physiol Rev 42: 554–604.

    CAS  PubMed  Google Scholar 

  • Peever JH, Lai YY, Siegel JM. 2003. Excitatory effects of hypocretin‐1 (orexin‐A) in the trigeminal motor nucleus are reversed by NMDA antagonism. J Neurophysiol 89: 2591–2600.

    CAS  PubMed  Google Scholar 

  • Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, et al 2000. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6: 991–997.

    CAS  PubMed  Google Scholar 

  • Peyron C, Tighe DK, van den Pol A, de Lecea L, Heller HC, et al 1998. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18: 9996–10015.

    CAS  PubMed  Google Scholar 

  • Piper DC, Upton N, Smith MI, Hunter AJ. 2000. The novel brain neuropeptide, orexin‐A, modulates the sleep‐wake cycle of rats. Eur J Neurosci 12: 726–730.

    CAS  PubMed  Google Scholar 

  • Porter RA, Chan WN, Coulton S, Johns A, Hadley MS, et al 2001. 1,3‐Biarylureas as selective non‐peptide antagonists of the orexin‐1 receptor. Bioorg Med Chem Lett 11: 1907–1910.

    CAS  PubMed  Google Scholar 

  • Pu S, Jain MR, Kalra PS, Kalra SP. 1998. Orexins, a novel family of hypothalamic neuropeptides, modulate pituitary luteinizing hormone secretion in an ovarian steroid‐dependent manner. Regul Pept 78: 133–136.

    CAS  PubMed  Google Scholar 

  • Qu D, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, et al 1996. A role for melanin‐concentrating hormone in the central regulation of feeding behaviour. Nature 380: 243–247.

    CAS  PubMed  Google Scholar 

  • Randeva HS, Karteris E, Grammatopoulos D, Hillhouse EW. 2001. Expression of orexin‐A and functional orexin type 2 receptors in the human adult adrenals: implications for adrenal function and energy homeostasis. J Clin Endocrinol Metab 86: 4808–4813.

    CAS  PubMed  Google Scholar 

  • Ranson SW. 1939. Somnolence caused by hypothalamic lesions in the monkey. Arch Neurol Psychiatr 41: 1–23.

    Google Scholar 

  • Reti IM, Reddy R, Worley PF, Baraban JM. 2002. Selective expression of Narp, a secreted neuronal pentraxin, in orexin neurons. J Neurochem 82: 1561–1565.

    CAS  PubMed  Google Scholar 

  • Ripley B, Overeem S, Fujiki N, Nevsimalova S, Uchino M, et al 2001. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 57: 2253–2258.

    CAS  PubMed  Google Scholar 

  • Rodgers RJ, Halford JCG, Nunes de Souza RL, Canto de Souza AL, Piper DC, et al 2001. SB‐334867, a selective orexin‐1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin‐A in rats. Eur J Neurosci 13: 1444–1452.

    CAS  PubMed  Google Scholar 

  • Rosin DL, Weston MC, Sevigny CP, Stornetta RL, Guyenet PG. 2003. Hypothalamic orexin (hypocretin) neurons express vesicular glutamate transporters VGLUT1 or VGLUT2. J Comp Neurol 465: 593–603.

    CAS  PubMed  Google Scholar 

  • Russell SH, Small CJ, Dakin CL, Abbott CR, Morgan DG, et al 2001a. The central effects of orexin‐A in the hypothalamic–pituitary–adrenal axis in vivo and in vitro in male rats. J Neuroendocrinol 13: 561–566.

    CAS  Google Scholar 

  • Russell SH, Small CJ, Kennedy AR, Stanley SA, Seth A, et al 2001b. Orexin A interactions in the hypothalamo‐pituitary gonadal axis. Endocrinology 142: 5294–5302.

    CAS  Google Scholar 

  • Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, et al 1998. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein‐coupled Receptors that regulate feeding behavior. Cell 92: 573–585.

    CAS  PubMed  Google Scholar 

  • Salomon R, Ripley B, Kennedy J, Johnson B, Schmidt D, et al 2003. Diurnal variation of cerebrospinal fluid hypocretin‐1 (orexin‐A) levels in control and depressed subjects. Biol Psychiatry 54: 96–104.

    CAS  PubMed  Google Scholar 

  • Samson WK, Gosnell B, Chang JK, Resch ZT, Murphy TC. 1999. Cardiovascular regulatory actions of the hypocretins in brain. Brain Res 831: 248–253.

    CAS  PubMed  Google Scholar 

  • Samson WK, Taylor MM. 2001. Hypocretin/orexin suppresses corticotroph responsiveness in vitro. Am J Physiol Regul Integr Comp Physiol 281: R1140–R1145.

    CAS  PubMed  Google Scholar 

  • Samson WK, Taylor MM, Follwell M, Ferguson AV. 2002. Orexin actions in hypothalamic paraventricular nucleus: physiological consequences and cellular correlates. Regul Pept 104: 97–103.

    CAS  PubMed  Google Scholar 

  • Saper CB, Chou TC, Scammell TE. 2001. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci 24: 726–731.

    CAS  PubMed  Google Scholar 

  • Sartin JL, Dyer C, Matteri R, Buxton D, Buonomo F, et al 2001. Effect of intracerebroventricular orexin‐B on food intake in sheep. J Anim Sci 79: 1573–1577.

    CAS  PubMed  Google Scholar 

  • Schuld A, Hebebrand J, Geller Fand Pollmacher T. 2000. Increased body‐mass index in patients with narcolepsy. Lancet 355: 1274–1275.

    CAS  PubMed  Google Scholar 

  • Sherin JE, Shiromani PJ, McCarley RW, Saper CB. 1996. Activation of ventrolateral preoptic neurons during sleep. Science 271: 216–219.

    CAS  PubMed  Google Scholar 

  • Shirasaka T, Nakazato M, Matsukura S, Takasaki M, Kannan H. 1999. Sympathetic and cardiovascular actions of orexins in conscious rats. Am J Physiol 277: R1780–R1785.

    CAS  PubMed  Google Scholar 

  • Shirasaka T, Miyahara S, Kunitake T, Jin QH, Kato K, et al 2001. Orexin depolarizes rat hypothalamic paraventricular nucleus neurons. Am J Physiol Regul Integr Comp Physiol 281: R1114–R1118.

    CAS  PubMed  Google Scholar 

  • Smart D, Jerman JC, Brough SJ, Rushton SL, Murdock PR, et al 1999. Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell‐line using FLIPR. Br J Pharmacol 128: 1–3.

    CAS  PubMed  Google Scholar 

  • Smart D, Sabido‐David C, Brough SJ, Jewitt F, Johns A, et al 2001. SB‐334867‐A: the first selective orexin‐1 receptor antagonist. Br J Pharmacol 132: 1179–1182.

    CAS  PubMed  Google Scholar 

  • Smith BN, Davis SF, van den Pol AN, Xu W. 2002. Selective enhancement of excitatory synaptic activity in the rat nucleus tractus solitarius by hypocretin 2. Neuroscience 115: 707–714.

    CAS  PubMed  Google Scholar 

  • Steriade M, McCormick DA, Sejnowski TJ. 1993. Thalamocortical oscillations in the sleeping and aroused brain. Science 262: 679–685.

    CAS  PubMed  Google Scholar 

  • Sutcliffe JG, de Lecea L. 2002. The hypocretins: setting the arousal threshold. Nat Rev Neurosci 3: 339–349.

    CAS  PubMed  Google Scholar 

  • Swart I, Michael Overton J, Houpt TA. 2001. The effect of food deprivation and experimental diabetes on orexin and NPY mRNA levels. Peptides 22: 2175–2179.

    CAS  PubMed  Google Scholar 

  • Taheri S, Mahmoodi M, Opacka‐Juffry J, Ghatei MA, Bloom SR. 1999. Distribution and quantification of immunoreactive orexin A in rat tissues. FEBS Lett 457: 157–161.

    CAS  PubMed  Google Scholar 

  • Takahashi N, Okumura T, Yamada H, Kohgo Y. 1999. Stimulation of gastric acid secretion by centrally administered orexin‐A in conscious rats. Biochem Biophys Res Commun 254: 623–627.

    CAS  PubMed  Google Scholar 

  • Thakkar MM, Ramesh V, Strecker RE, McCarley RW. 2001. Microdialysis perfusion of orexin‐A in the basal forebrain increases wakefulness in freely behaving rats. Arch Ital Biol 139: 313–28.

    CAS  PubMed  Google Scholar 

  • Thakkar MM, Winston S, McCarley RW. 2002. Orexin neurons of the hypothalamus express adenosine A1 receptors. Brain Res 944: 190–194.

    CAS  PubMed  Google Scholar 

  • Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, et al 2000. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27: 469–474.

    CAS  PubMed  Google Scholar 

  • Torrealba F, Yanagisawa M, Saper CB. 2003. Colocalization of orexin A and glutamate immunoreactivity in axon terminals in the tuberomammillary nucleus in rats. Neuroscience 119: 1033–1044.

    CAS  PubMed  Google Scholar 

  • Tritos NA, Mastaitis JW, Kokkotou E, Maratos‐Flier E. 2001. Characterization of melanin concentrating hormone and preproorexin expression in the murine hypothalamus. Brain Res 895: 160–166.

    CAS  PubMed  Google Scholar 

  • Trivedi P, Yu H, MacNeil DJ, Van der Ploeg LHT, Guan X‐M. 1998. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 438: 71–75.

    CAS  PubMed  Google Scholar 

  • Upton N. 2005. In vivo pharmacology of orexins (hypocretin) receptors. The hypocretins as integrators of physiological signals. de Lecea L, Sutcliffe JG, editor. New York: Springer; pp. 203–218.

    Google Scholar 

  • Uramura K, Funahashi H, Muroya S, Shioda S, Takigawa M, et al 2001. Orexin‐a activates phospholipase C‐ and protein kinase C‐mediated Ca2+ signaling in dopamine neurons of the ventral tegmental area. Neuroreport 12: 1885–1889.

    CAS  PubMed  Google Scholar 

  • van den Pol AN. 1999. Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J Neurosci 19: 3171–3182.

    CAS  PubMed  Google Scholar 

  • van den Pol AN, Gao XB, Obrietan K, Kilduff TS, Belousov AB. 1998. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J Neurosci 18: 7962–7971.

    CAS  PubMed  Google Scholar 

  • von Economo C. 1930. Sleep as a problem of localization. J Nerv Ment Dis 71: 249–259.

    Google Scholar 

  • Wang J, Osaka T, Inoue S. 2001. Energy expenditure by intracerebroventricular administration of orexin to anesthetized rats. Neurosci Lett 315: 49–52.

    CAS  PubMed  Google Scholar 

  • Willie JT, Chemelli RM, Sinton CM, Tokita S, Williams SC, et al 2003. Distinct narcolepsy syndromes in Orexin receptor‐2 and Orexin null mice: molecular genetic dissection of Non‐REM and REM sleep regulatory processes. Neuron 38: 715–730.

    CAS  PubMed  Google Scholar 

  • Winsky‐Sommerer R, Yamanaka A, Diano S, Roberts AJ, Sakurai T, et al 2004. Interaction between the corticotropin‐releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J Neurosci 24: 11439–11448.

    PubMed  Google Scholar 

  • Wu M, Zaborszky L, Hajszan T, van den Pol AN, Alreja M. 2004. Hypocretin/orexin innervation and excitation of identified septohippocampal cholinergic neurons. J Neurosci 24: 3527–3536.

    CAS  PubMed  Google Scholar 

  • Xi MC, Morales FR, Chase MH. 2001. Effects on sleep and wakefulness of the injection of hypocretin‐1 (orexin‐A) into the laterodorsal tegmental nucleus of the cat. Brain Res 901: 259–264.

    CAS  PubMed  Google Scholar 

  • Yamamoto Y, Ueta Y, Nakazato M, Hara Y, Serino R, et al 1999. Down regulation of the prepro‐orexin gene expression in genetically obese mice. Brain Res Mol Brain Res 65: 14–22.

    CAS  PubMed  Google Scholar 

  • Yamanaka A, Kunii K, Nambu T, Tsujino N, Sakai A, et al 2000. Orexin‐induced food intake involves neuropeptide Y pathway. Brain Res 859: 404–409.

    CAS  PubMed  Google Scholar 

  • Yamanaka A, Muraki Y, Tsujino N, Goto K, Sakurai T. 2003. Regulation of orexin neurons by the monoaminergic and cholinergic systems. Biochem Biophys Res Commun 303: 120–129.

    CAS  PubMed  Google Scholar 

  • Yamanaka A, Sakurai T, Katsumoto T, Yanagisawa M, Goto K. 1999. Chronic intracerebroventricular administration of orexin‐A to rats increases food intake in daytime, but has no effect on body weight. Brain Res 849: 248–252.

    CAS  PubMed  Google Scholar 

  • Yamanaka A, Tsujino N, Funahashi H, Honda K, Guan JL, et al 2002. Orexins activate histaminergic neurons via the orexin 2 receptor. Biochem Biophys Res Commun 290: 1237–1245.

    CAS  PubMed  Google Scholar 

  • Yamuy J, Fung SJ, Xi M, Chase MH. 2004. Hypocretinergic control of spinal cord motoneurons. J Neurosci 24: 5336–5345.

    CAS  PubMed  Google Scholar 

  • Yasuda Y, Takeda A, Fukuda S, Suzuki H, Ishimoto M, Mori Y, et al 2003. Orexin a elicits arousal electroencephalography without sympathetic cardiovascular activation in isoflurane‐anesthetized rats. Anesth Analg 97: 1663–1666.

    CAS  PubMed  Google Scholar 

  • Yoshida Y, Fujiki N, Maki R, Schwarz D, Nishino S. 2003. Differential kinetics of hypocretins in the cerebrospinal fluid after intracerebroventricular administration in rats. Neurosci Lett 346: 182–186.

    CAS  PubMed  Google Scholar 

  • Yoshida Y, Fujiki N, Nakajima T, Ripley B, Matsumura H, et al 2001. Fluctuation of extracellular hypocretin‐1 (orexin A) levels in the rat in relation to the light‐dark cycle and sleep‐wake activities. Eur J Neurosci 14: 1075–1081.

    CAS  PubMed  Google Scholar 

  • Yoshimichi G, Yoshimatsu H, Masaki T, Sakata T. 2001. Orexin‐A regulates body temperature in coordination with arousal status. Exp Biol Med 226: 468–476.

    CAS  Google Scholar 

  • Zhu Y, Card JP, Aston‐Jones G. 2003. Frequent hypocretin innervation of GABA neurons in the peri‐locus coeruleus region: ultrastructural studies. Soc Neurosci Abstract 29: 931.15.

    Google Scholar 

  • Zhu Y, Yamanaka A, Kunii K, Tsujino N, Goto K, et al 2002. Orexin‐mediated feeding behavior involves both leptin‐sensitive and ‐insensitive pathways. Physiol Behav 77: 251–257.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Supported in part by grants from the National Institutes of Health (GM32355, MH58543).

Authors
  1. J. G. Sutcliffe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. de Lecea
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Center for Neurochemistry, Nathan S. Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, 10962, Orangeburg, Newyork, USA

    Abel Lajtha (Director) (Director)

  2. Department of Neurology (Division of Neurochemistry and Neurobiology), University of Iowa College of Medicine and Veterans Administration Medical Center, 52242, lowa, lowa, USA

    Ramon Lim

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, LLC

About this entry

Cite this entry

Sutcliffe, J.G., de Lecea, L. (2006). Hypocretins/Orexins in Brain Function. In: Lajtha, A., Lim, R. (eds) Handbook of Neurochemistry and Molecular Neurobiology. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-30381-9_22

Download citation

Publish with us

Policies and ethics

Search

Navigation